Navigation Links
Gloucester Pharmaceuticals Reports Positive Interim Phase II Data,on Romidepsin for T-Cell Lymphomas at the 2007 American Society of,Clinical Oncology Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 5, 2007 - Gloucester Pharmaceuticals, Inc., a privately held cancer therapeutics development company, today announced that data for romidepsin as a treatment for cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL) were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL. The data presented are part of an interim analysis of a phase II study of romidepsin sponsored by the National Cancer Institute (NCI) under a Cooperative Research and Development Agreement (CRADA) with Gloucester.

Data from the NCI's ongoing clinical trial of romidepsin was presented in Abstract #8027 "Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma" on Monday, June 4th.

The interim results reported on 70 patients with CTCL and 39 patients with PTCL. In the CTCL patient group 4 of 70 patients, or 6%, achieved a complete response, with the duration of response ranging from 8 to 63+ months. A partial response was observed in 18 of 70 patients, or 26%, with the duration of response ranging from 1 to 69+ months. The most common adverse events reported were nausea, vomiting, fatigue, transient granulocytopenia and thrombocytopenia, and anorexia.

Commenting on the data from the NCI's study, William McCulloch, M.B., FRCP, Executive Vice President and Chief Medical Officer at Gloucester said, "Clinical evidence for romidepsin's value in the treatment of T-cell lymphomas continues to build. Based on the data from this trial, as well as interim data from our own Gloucester-sponsored CTCL pivotal phase II study which is nearing completion, we remain enthusiastic about the clinical prospects for romidepsin."

In the PTCL patient group 3 of 39 patients, or 7%, achieved a complete response, with the duration of response ranging from 9 to 43+ months. A partial respons
'"/>




Page: 1 2 3

Related medicine technology :

1. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
2. Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib Combination in Non-Small Cell Lung Cancer Presented at American Association of Cancer Research Annual Meeting
3. Gloucester Pharmaceuticals Announces Multiple Presentations of Preclinical Romidepsin Data at American Association of Cancer Research Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:8/28/2014)... 2014  In recognition of the increased risks ... the flu, pneumonia, shingles and other illnesses, CVS/pharmacy ... September to be Senior Vaccination Month. Because people,s ... important that adults ages 65 years and older ... pharmacists and MinuteClinic nurse practitioners and physician assistants ...
(Date:8/28/2014)... Pa. , Aug. 28, 2014  Robotic ... patients, and media, both for the promise of ... safety. The quick deployment of surgical robots and ... are prompting facilities to evaluate their robotic surgery ... entire surgical team.    ECRI Institute ...
(Date:8/28/2014)... Aug. 28, 2014  A decline in revenues ... are adding pressure to pharmaceutical, biotechnology and medical ... continue to shrink and approval processes and postapproval ... companies to look for additional support and expertise ... keeping approved products on the market.  ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 54 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4
... 2007 /PRNewswire-USNewswire/ -- The,following statement may be attributed ... Medical Research (CAMR): , "In the face of ... the stroke of his veto pen deliberately to ... well as endanger,the future health and well being ...
... - Elixir,Pharmaceuticals, Inc., announced today the publication ... (mitiglinide calcium,hydrate) monotherapy, or combination therapy with ... meals. The data were,published in the Abstract ... Scientific Sessions in Chicago, Illinois.,Glufast is an ...
Cached Medicine Technology:President Bush Ignores America's Plea for Support of Stem Cell,Research 2Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 2Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 3Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 4Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 5
(Date:8/28/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses ... range of fashionable bridesmaid dresses . Along with that, ... are offered with big discounts, from 15 to 65 percent ... 16. , The company’s experienced workers never compromise on ... all its products are trendy and graceful. , “We are ...
(Date:8/28/2014)... DE (PRWEB) August 28, 2014 Blood's Thicker ... gunplay, sex, money and family ties in the heart of ... no other – a story about how disrespect caused two ... limbs on many streets. , The Yayo Boyz and the ... news reporters speechless and local onlookers in a silent terror. ...
(Date:8/28/2014)... 2014 Millennium Treatment Group is ... This month will be a celebration of the ... services. Along with other treatment facilities and mental ... spread the word about this national observance. , ... work of treatment and recovery professionals, and has ...
(Date:8/28/2014)... 2014 Millennium Treatment Group recently announced a ... large, and Millennium Treatment Group is working to close it, ... need. , According to the National Survey on Drug ... Americans could have benefited from treatment for drug and/or substance ... This means that there is a large treatment gap in ...
(Date:8/28/2014)... Ariz. (PRWEB) August 28, 2014 Arizona ... Force Impact Technologies , has been named one of ... the Year competition. , This is the fourth consecutive ... in the competition. Jared Schoepf, co-founder of SafeSIPP, and ... 2013 and 2012, respectively. In 2011, ASU dominated the ...
Breaking Medicine News(10 mins):Health News:Fashionable Bridesmaid Dresses for Autumn 2014 from iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3
... Dengue fever has infected almost 20,000 people in Vietnam in ... seven more than in the same period last year, the ... have been blamed for the nearly 15 percent rise to ... concentrated in the poverty-stricken southern Mekong delta. ,Malaysia ...
... figure of those wounded in the killing fields of Iraq or ... keep track of 3,500 in Iraq for instance. But in ... ,But more important the precise numbers it is the ... has caused concerns all round. ,More than 800 of ...
... crusade for the rights of mentally ill and disabled children ... motion last year. ,Rowling is carrying on ... children kept in cages in institutions in East Europe. ... Level Group, which fights for better rights for children in ...
... summer vibrates with expressions of insect love and desire. The ... how an emitting sex attracts conspecific members of the ... humans, are also signals by which females guide males towards ... tend to be very specific, hence they are thought to ...
... funny man Jim Carreys lady love Jenny McCarthy has revealed her ... actress insisted that the couple will be spending as much time ... beach. We like to sit and do nothing. Stare at the ... ,The 34-year-old will be spending a lot of time with her ...
... California, San Diego (UCSD) Skaggs School of Pharmacy and ... human vaccine to prevent against Human Cytomegalovirus (hCMV) ... herpes virus, is the leading viral cause of birth ... immune systems. The bodys natural immunity doesnt protect against ...
Cached Medicine News:Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 2Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 3Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 4Health News:JK Rowling Intensifies Her Disabled Children's Rights Crusade 2Health News:Another Sexual Attraction is Possible ... 2Health News:Human Vaccine for Herpes Virus on the Anvil 2Health News:Human Vaccine for Herpes Virus on the Anvil 3
...
...
...
... Platform for Pure Harmonic Detection , ... in our ProSound line of superior ... technology provides distortion-free fundamental frequency transmission, ... This technology is especially effective for ...
Medicine Products: